IUPAC/Chemical Name
(5R,6S,9a1R,14aR,Z)-3-ethylidene-6-hydroxy-6-(hydroxymethyl)-5-methyl-3,4,5,6,9,9a1,11,14a-octahydro-[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7,14(13H)-trione
InChi Key
FLQSQSWCFNNRPQ-RDKZJRQNSA-N
InChi Code
InChI=1S/C18H23NO7/c1-3-11-6-10(2)18(24,9-20)17(23)25-8-12-4-5-19-7-13(21)15(14(12)19)26-16(11)22/h3-4,10,14-15,20,24H,5-9H2,1-2H3/b11-3-/t10-,14-,15+,18-/m1/s1
SMILES Code
O=C(O[C@@]1([H])C(CN2[C@]1([H])C(COC([C@](CO)(O)[C@H](C)C/3)=O)=CC2)=O)C3=C/C
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
365.38
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Kevekordes S, Spielberger J, Burghaus CM, Birkenkamp P, Zietz B, Paufler P, Diez M, Bolten C, Dunkelberg H. Micronucleus formation in human lymphocytes and in the metabolically competent human hepatoma cell line Hep-G2: results with 15 naturally occurring substances. Anticancer Res. 2001 Jan-Feb;21(1A):461-9. PubMed PMID: 11299780.
2: Müller L, Kasper P, Kaufmann G. The clastogenic potential in vitro of pyrrolizidine alkaloids employing hepatocyte metabolism. Mutat Res. 1992 Jul;282(3):169-76. PubMed PMID: 1378549.
3: Isatidine. IARC Monogr Eval Carcinog Risk Chem Man. 1976;10:269-73. Review. PubMed PMID: 186388.
4: SCHOENTAL R, HEAD MA, PEACOCK PR. Senecio alkaloids; primary liver tumours in rats as a result of treatment with (1) a mixture of alkaloids from S. jacobaea Lin.; (2) retrorsine; (3) isatidine. Br J Cancer. 1954 Sep;8(3):458-65. PubMed PMID: 13230379; PubMed Central PMCID: PMC2007966.
5: Müller-Tegethoff K, Kersten B, Kasper P, Müller L. Application of the in vitro rat hepatocyte micronucleus assay in genetic toxicology testing. Mutat Res. 1997 Aug 1;392(1-2):125-38. Review. PubMed PMID: 9269337.
6: Chu PS, Lamé MW, Segall HJ. In vivo metabolism of retrorsine and retrorsine-N-oxide. Arch Toxicol. 1993;67(1):39-43. PubMed PMID: 8452478.
7: Uhl M, Helma C, Knasmüller S. Evaluation of the single cell gel electrophoresis assay with human hepatoma (Hep G2) cells. Mutat Res. 2000 Jul 10;468(2):213-25. PubMed PMID: 10882898.
8: Roseman DM, Wu X, Kurth MJ. Enzyme-linked immunosorbent assay detection of pyrrolizidine alkaloids: immunogens based on quaternary pyrrolizidinium salts. Bioconjug Chem. 1996 Mar-Apr;7(2):187-95. PubMed PMID: 8983340.
9: Kevekordes S, Mersch-Sundermann V, Burghaus CM, Spielberger J, Schmeiser HH, Arlt VM, Dunkelberg H. SOS induction of selected naturally occurring substances in Escherichia coli (SOS chromotest). Mutat Res. 1999 Sep 15;445(1):81-91. PubMed PMID: 10521693.
10: Wang YP, Fu PP, Chou MW. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo. Int J Environ Res Public Health. 2005 Apr;2(1):74-9. PubMed PMID: 16705803; PubMed Central PMCID: PMC3814699.
11: Wang YP, Yan J, Fu PP, Chou MW. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid. Toxicol Lett. 2005 Mar 15;155(3):411-20. PubMed PMID: 15649625.
12: Hol WH, Van Veen A. Pyrrolizidine alkaloids from Senecio jacobaea affect fungal growth. J Chem Ecol. 2002 Sep;28(9):1763-72. PubMed PMID: 12449504.
